Laínez Nuria - Department of Medical Oncology, Complejo Hospitalario de Navarra

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 118 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Reno study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain

Laura Basterretxea Badiola,Nuria Lainez Milagro, Diego Cacho Lavín, Sandra López Peraita, Mikel Arruti Ibarbia, Mireia Martínez Kareaga, Teresa de Portugal Fernández del Rivero, Diego Soto de Prado Otero, Valentín Alija López, Carlos Álvarez Fernández, Alejandra Lacalle Emborujo, Irene Gil Arnaiz,

Seminars in Oncology (2024)

Cited0Views0WOSBibtex

PBRM1 and KDM5C cooperate to define high-angiogenesis tumors and increased antiangiogenic response in renal cancer

María Santos,Javier Lanillos,Eduardo Caleiras,Carlos Valdivia,Juan M Roldan-Romero,Nuria Laínez,Javier Puente,Benoit Beuselinck, Stéphane Oudard,Jessica Zucman-Rossi,Paloma Navarro, Mercedes Robledo,

American journal of cancer researchno. 5 (2023): 2116-2125

Cited1Views0WOSBibtex

Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO ( GR anulosa E t K et O conazole) trial, GETHI 2011-03

Jesus Garcia-Donas,Alicia Hurtado,Laia Garrigos,Ana Santaballa,Andres Redondo,Laura Vidal,Nuria Lainez,Eva Guerra,Victor Rodriguez,Juan Cueva,Isabel Bover,Isabel Palacio,

SSRN Electronic Journalno. 7 (2023): 2090-2098

Cited0Views0WOSBibtex

Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trial

Miguel Ángel Climent,Carlos Álvarez,Rafael Morales,Pablo Maroto,Alejo Rodríguez-Vida,María José Méndez-Vidal,Xavier García del Muro,Javier Puente,Nuria Láinez,Sergio Vázquez,Daniel Castellano, Carmen Gómez Lang,

Clinical and Translational Oncologypp.1-7, (2023)

Cited0Views0WOSBibtex

Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study

Nuria Romero-Laorden,David Lorente,Guillermo de Velasco,Rebeca Lozano, Bernardo Herrera,Javier Puente,Pedro P. López,Ana Medina,Elena Almagro,Enrique Gonzalez-Billalabeitia, Jose Carlos Villla-Guzman,Aránzazu González-del-Alba,

European Urology Oncologyno. 3 (2023): 447-455

Cited0Views0WOSBibtex

SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)

María José Méndez-Vidal,Martin Lázaro Quintela,Nuria Lainez-Milagro,Begoña Perez-Valderrama,Cristina Suárez Rodriguez,José Ángel Arranz Arija,Ignacio Peláez Fernández,Enrique Gallardo Díaz, Julio Lambea Sorrosal,Aránzazu González-del-Alba

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexicono. 9 (2023): 2732-2748

Cited1Views0WOSBibtex

Recent therapeutic advances in urothelial carcinoma: A paradigm shift in disease management

Joaquim Bellmunt,Begoña P. Valderrama,Javier Puente,Enrique Grande,M. Victoria Bolós,Nuria Lainez,Sergio Vázquez,Pablo Maroto,Miguel Ángel Climent,Xavier Garcia del Muro,José Ángel Arranz,Ignacio Durán

Critical Reviews in Oncology/Hematology（2022）

Cited7Views0WOSBibtex

Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study

Álvaro Pinto,Oscar Reig,Clara Iglesias,Enrique Gallardo,Xavier García-Del Muro,Teresa Alonso,Georgia Anguera,Cristina Suárez,José Muñoz-Langa, Laura Villalobos-León,Ángel Rodríguez-Sánchez,Nuria Lainez,

CLINICAL GENITOURINARY CANCER（2022）

Cited1Views0WOSBibtex

Time without symptoms or toxicity (TWiST) in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib or placebo plus bevacizumab: Analysis of PAOLA-1/ENGOT-ov25 phase III trial

Florence Joly,Sylvie Chabaud,Claire Cropet,Amélie Anota,Martin Demarchi,Beyhan Atasevan,Carmen Pisano,Nuria Lainez,Irina Tsibulak,Kan Yonemori, Ignace Vergote, Maria Lapresa,

Journal of Clinical Oncology（2022）

Cited0Views0Bibtex

Comprehensive molecular characterization of muscle-invasive bladder cancer (MIBC) treated with durvalumab plus olaparib in the neoadjuvant setting: Neodurvarib trial

Juan Francisco Rodriguez-Moreno,Sergio Ruiz-Llorente,Guillermo De Velasco,Carlos Alvarez-Fernandez,Ricardo Collado Martin,Ricardo Fernandez,Sergio Vazquez-Estevez,Juan Antonio Virizuela,Pablo Gajate,Albert Font,Nuria Lainez,Arantzazu Barquin,

JOURNAL OF CLINICAL ONCOLOGY（2022）

Cited3Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn